Emerging Agents in the Pipeline for Merkel Cell Carcinoma
3 Ansichten
• 07/17/23
0
0
Einbetten
administrator
Abonnenten
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare